Paracentesis clinical trials

Explore recruiting paracentesis clinical trials.

Recruiting paracentesis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Paracentesis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects with Compensated Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Spain, Hungary, Netherlands, Belgium, Bulgaria, Germany +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

ALBUMINUS: Dose reduction of human albumin during large-volume paracentesis in patients with cirrhosis

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

An Open-label Phase 1/2 Multicentre Study to Evaluate the Safety, Tolerability and Efficacy of RTX001 Autologous Macrophages in Participants with Liver Cirrhosis who have Hepatic Decompensation (EMERALD)

Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

AFFIRM: A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

Germany, Italy, France, Hungary, Greece, Czechia +7 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

ALB-TRIAL: Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites

Denmark, Belgium, Spain, Netherlands, Germany, Hungary

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Double-blind, Placebo-controlled, Phase 2/3 Study to Assess the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Obeticholic Acid Compared to Placebo in Pediatric Subjects with Biliary Atresia, Post-hepatoportoenterostomy

Belgium, Germany, Netherlands, France, Italy, Spain +1 more

Phase II and Phase III (Integrated) EU CTIS Study details

Paracentesis trials by city

Paracentesis in Toronto Paracentesis in Vancouver Paracentesis in Montreal Paracentesis in Calgary Paracentesis in Edmonton Paracentesis in Ottawa Paracentesis in Winnipeg Paracentesis in Quebec City Paracentesis in Hamilton Paracentesis in Kitchener Paracentesis in London Paracentesis in Halifax Paracentesis in New York Paracentesis in Los Angeles Paracentesis in Chicago Paracentesis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease